Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$740,218,912
+$160,404,099 QoQ
Shares Held
6,666,837
0.0% QoQ
Ownership
9.68%
of shares outstanding
% of Portfolio
6.52%
of 13F equity value
Holder Rank
#1
of 299 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. RYTM ranks #3 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in RYTM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $740,218,912 | 6,666,837 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $579,814,813 | 6,666,837 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $713,618,232 | 6,666,837 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $573,760,445 | 5,681,359 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $351,422,275 | 5,561,359 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $322,291,303 | 6,084,412 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $340,605,383 | 6,084,412 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $318,762,344 | 6,084,412 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $249,825,956 | 6,084,412 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $230,966,751 | 5,330,412 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $245,039,039 | 5,330,412 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $130,123,835 | 5,676,067 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $93,598,344 | 5,676,067 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $98,406,635 | 5,516,067 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $160,627,871 | 5,516,067 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $134,041,141 | 5,471,067 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,214,928 | 4,871,067 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $56,114,691 | 4,871,067 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $48,613,248 | 4,871,067 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $63,616,135 | 4,871,067 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $95,375,491 | 4,871,067 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $103,607,595 | 4,871,067 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $124,243,661 | 4,179,067 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $111,392,641 | 5,140,408 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $116,184,962 | 5,210,088 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $82,527,588 | 5,422,312 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||